exenatide vs semaglutide Liraglutide vs. Semaglutide: What is the Difference? Advances in GLP-1 receptor agonists

One clinical trial reported that adults taking Zepbound for 72 weeks lost an average of 35.5 pounds when taking the lowest dose of 5 milligrams per week

Statistical evaluation of the data was carried out using Student t-test, 1- or 2- way ANOVA with Tukey post-hoc analysis (One-way) or Sidak post-hoc analysis (Two-way) between control and treatment groups in cases in which statistical significance was established

Powers SK, Jackson MJ

Medicare beneficiaries will have access to some GLP-1 drugs approved for both obesity and diabetes for a $50 copay

Less commonly, alopecia areata, traction alopecia, diffuse unpatterned alopecia, or an inflammatory or scarring disorder may be responsible